Medtronic

Medtronic plc, a prominent entity in the Medical, precision and optical instruments, watches and clocks industry, headquartered in the US, has outlined ambitious climate commitments alongside its carbon emissions data. For the fiscal year 2025, the company reported Scope 1 emissions of approximately 174,000,000 kg CO2e, Scope 2 emissions of approximately 79,000,000 kg CO2e, and Scope 3 emissions totalling approximately 970,000,000 kg CO2e. The most significant contributors to their Scope 3 emissions include purchased goods and services (approximately 3,651,000,000 kg CO2e), upstream transportation and distribution (approximately 461,000,000 kg CO2e), and business travel (approximately 209,000,000 kg CO2e).

In terms of climate targets, Medtronic has committed to becoming carbon neutral in its operations by fiscal year 2030. A significant near-term goal is to reduce greenhouse gas emissions by 50% by fiscal year 2025, compared to a fiscal year 2020 baseline. Furthermore, Medtronic PLC has committed to reduce absolute scope 1 and 2 greenhouse gas emissions by 52% by FY2030 from a FY2020 base year. They also aim to increase their sourcing of renewable electricity to 100% by FY2030 and ensure that 75% of their suppliers, by emissions covering purchased goods and services and capital goods, will have science-based targets by FY2030. An additional commitment is to reduce absolute scope 3 greenhouse gas emissions from upstream transportation and distribution, business travel, and end-of-life treatment of sold products by 37.5% by FY2034 from a FY2024 base year. These targets are aligned with keeping warming to 1.5°C.